Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
Wavelet is on a mission to eliminate preventable brain injury at birth and reduce unnecessary caesarean sections, improving the lives...
Brain
MIB to provide individual access to electronic health records through exclusive partnership with Agentic Healthcare
BRAINTREE, Mass., April 14, 2026 /PRNewswire/ -- MIB, the life insurance industry's most trusted and secure partner for data-driven insights...
CBD Life Sciences Inc. (CBDL) Announces Our Collection of Adaptogenic Mushroom Products
The natural, functional mushroom market is experiencing rapid growth, projected to exceed USD 60 billion by 2030, driven by rising...
Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor
FDA assigned PDUFA target action date of January 29, 2027 No advisory committee meeting expected BOSTON, April 14, 2026 (GLOBE...
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease
Findings underpin the scientific rationale for Anavex’s targeted autophagy approach with orally administered blarcamesine Convergence of impaired autophagy and synaptic...
Medicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
TORONTO and HOUSTON, April 14, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage...
Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress
BOSTON, April 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead...
FDA Accepts NDA for TLX101-Px (Pixclara®)
MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces...
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Siemens Healthineers for the Transformative Bio-Hermes-002 Study
Siemens Healthineers joins collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and dementiasWASHINGTON, April 09,...
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
Eight studies demonstrate how clinically relevant models and integrated data can reduce translational risk and guide development decisions HACKENSACK, NJ...
Research Reveals Chronic Stress is Rewiring Your Brain, New Book Shows How to Reverse it
Clinical studies link modern stress to measurable changes in brain architecture, fueling a new movement toward "brain fitness."NEW BERN, N.C.,...
CORRECTING and REPLACING Petwealth Emerges from Stealth with $1.7 Million in Funding, Landmark Partnerships, and a Mission to Become the Functional Health Platform for Pets
The Miami-based diagnostics company launches publicly with exclusive partnerships with Kennel Connection and Pawp, bringing clinical-grade pet health intelligence to...
Peer Reviewed Study Validates Creyos as a Faster, More Sensitive Approach to Dementia Detection in Primary Care
As dementia cases rise globally, more physicians and researchers are pointing to early intervention to improve patient outcomesPublished in the...
Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.
North Bergen, New Jersey--(Newsfile Corp. - April 8, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company" or "Apollo"), in...
Precision Neuroscience™ Appoints Craig Mermel as Chief AI and Data Officer
As brain–computer interfaces advance, neural data emerges as a key asset.NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience...
Precision Neuroscience™ Appoints Craig Mermel as Chief AI and Data Officer
As brain–computer interfaces advance, neural data emerges as a key asset.NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience...
New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia
- Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to...
Life Biosciences Secures $80 Million Series D Financing
Funding to support the Phase 1 clinical trial of ER-100 in optic neuropathies and further investigation of new candidates from...
Cerevance to Participate in the 25th Annual Needham Virtual Healthcare Conference
BOSTON, April 08, 2026 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing targeted therapies for neurodegenerative diseases and obesity,...
Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile
Access the Moleculin CEO Corner here HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or...